Literature DB >> 8293747

Ultrasonography is more effective than computed tomography in excluding invasion of the carotid wall by cervical lymphadenopathies.

L Zaragoza1, F Sendra, J Solano, V Garrido, M Martínez-Morillo.   

Abstract

Twelve patients with head and neck cancer, bulky lymphadenopathies, and clinical suspicion of carotid artery infiltration, had preoperative CT and US. The results of both techniques were correlated with surgical findings (one case of invasion and 11 of non-invasion), to evaluate the role of CT and US in the preoperative diagnosis of tumor invasion of the carotid wall. While CT showed a high level of failures (11 false positives and one true positive), US (one true positive, one false negative, and 10 true negatives) appears to be an easy and helpful method for predicting non-invasion of the carotid wall. However, the usefulness of US in detecting invasion cannot be evaluated, due to the limited number of positive cases.

Entities:  

Mesh:

Year:  1993        PMID: 8293747     DOI: 10.1016/0720-048x(93)90102-s

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  3 in total

1.  Analysis of passive motion of para- and retropharyngeal structures during swallowing using dynamic magnetic resonance imaging.

Authors:  Shun-ichi Chitose; Masahiro Haraguchi; Shuji Nagata; Reiji Katayama; Kiminori Sato; Mioko Fukahori; Shintaro Sueyoshi; Takashi Kurita; Toshi Abe; Tadashi Nakashima
Journal:  Dysphagia       Date:  2014-05-24       Impact factor: 3.438

2.  Value of MR and CT Imaging for Assessment of Internal Carotid Artery Encasement in Head and Neck Squamous Cell Carcinoma.

Authors:  W L Lodder; C A H Lange; H J Teertstra; F A Pameijer; M W M van den Brekel; A J M Balm
Journal:  Int J Surg Oncol       Date:  2013-01-29

3.  Fatal bleeding in a nasopharyngeal carcinoma patient after concurrent chemoradiation plus cetuximab: a case report.

Authors:  Lingyan Zheng; Senxiang Yan; Danfang Yan; Jingsong Yang; Yixiang Wang
Journal:  Onco Targets Ther       Date:  2013-06-13       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.